LEXINGTON, Mass., Oct. 27, 2016-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced ...
- Capital Cube•10 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Curis, Inc. Here are 5 ETF’s with the largest exposure to CRIS-US. Comparing the performance and risk of Curis, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- GlobeNewswire•17 days ago
LEXINGTON, Mass., Oct. 11, 2016-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, today ...
Curis, Inc. (CRIS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||2.51 x 300|
|Day's Range||2.63 - 2.79|
|52wk Range||1.25 - 3.42|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-8.57|
|Avg Vol (3m)||591,844|
|Dividend & Yield||N/A (N/A)|